1009 Friday IPOs
BioCentury & Getty Images


Kronos’ post-IPO gains build on $1B+ postmoney valuation

Two other biotechs also rise in aftermarket as queue swells

Oct 9, 2020 | 10:10 PM GMT

Shares of Kronos climbed 42% in their first day of trading Friday, adding to a postmoney valuation that had already topped

Read the full 509 word article

How to gain access

Continue reading with a
two-week free trial.